Production of controlled release oral drug delivery system using β-lactoglobulin nanoparticle
- سال انتشار: 1395
- محل انتشار: چهاردهمین همایش بیوشیمی فیزیک ایران
- کد COI اختصاصی: CBC14_002
- زبان مقاله: انگلیسی
- تعداد مشاهده: 659
نویسندگان
Department of Medical Nanotechnology, Science and Research Branch, Islamic Azad University, Tehran, Iran
Department of Cell & Molecular Biology‚ Faculty of Biological Sciences, Kharazmi University, Tehran, Iran
Institute of Biochemistry and Biophysics‚ University of Tehran, Tehran, Iran
چکیده
Over the past decades many efforts have been done to producecontrolled vehicle for sustained release oraldrug delivery system. The present study was performed whereas biopolymers were illustrated their abilityfor presence in nano-scale oral drug delivery system. Moreover, previous studies have shown β-Lactoglobulin (β-LG) as a milk whey carrier protein due to its unique physicochemical properties isknown as a well promising candidate for presence in oral drug delivery system [1-3]. In this study, β-LGnanoparticles contain metal based drug were fabricated in the presence of low methoxyl pectin as extralayer at various conditions. β-LG nanoparticles were characterized by dynamic light scattering andscanning electron microscopy so that the obtained results illustrated that the particle size average is lowerthan 200 nm and their shape is spherically. To determine controlled release manner of drug from β-LGnanoparticles, the in vitro drug release were studied using equilibrium dialysis methods at 37 °C during inthe simulation conditions of gastrointestinal (GI) tract. The results were investigated by fitting intomathematical kinetics models so that the Korsmeyer-Peppas model was the best kinetics release model. Inaddition, data illustrated that β-LG nanoparticles were resistance to acidic condition. Hence, anomalousnon-Fickian pattern was determined for drug release in the simulation time such erosion and diffusionwere occurred dependent on alkaline pH conditions of GI. Consequently, based on our findings β-LGnanoparticle is promising candidate with unique pH sensitivityfor presence in controlled release oral drugdelivery system.کلیدواژه ها
β-LG nanoparticles, oral drug delivery, mathematical modeling, anomalous non-Fickianمقالات مرتبط جدید
- بررسی اثرات انتشار امواج لرزه ای در سازههای قاب خمشی دسته شده و هگزاگرید دارای پارامتر سختی یکسان
- شناسایی آزمایشگاهی ترک طولی تراورس بتنی پیش تنیده با استفاده از تست مودال تجربی
- Investigation of Transmission Loss and Absorptioncoefficient of the PU Composite Panels forConstruction Application
- Comprehensive Analysis of the Effect of Polyisobutyl-ene (PIB) Molecular Weight on Damping Properties of Butyl-Based Constrained Layer Damping Systems
- REVIEWING THE OBERST BEAM METHOD AND ITS AP-PLICATION IN CONSTRAINED LAYER DAMPING FOR AUTOMOTIVE NOISE, VIBRATION, AND HARSHNESS (NVH) CONTROL
اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.